Immunity

Immunity is a premier peer-reviewed journal published by Cell Press, dedicated to advancing the understanding of the immune system in health and disease. With an Impact Factor of 30.600 (2026) and consistently ranked in the JCR Q1 quartile, it stands among the most influential and highly cited publications in the fields of immunology and biomedical research. The journal’s scope encompasses the full breadth of immunological science, from fundamental molecular and cellular mechanisms to translational studies and clinical immunology. Key topics include innate and adaptive immunity, immune regulation, inflammation, autoimmunity, infectious disease, tumor immunology, and the development of immunotherapies. Immunity primarily publishes original research articles that present major conceptual advances or significant mechanistic insights, alongside review articles, perspectives, and commentaries that synthesize current knowledge and highlight emerging trends. The target audience comprises academic researchers, clinicians, and industry professionals specializing in immunology, as well as scientists in related disciplines such as cell biology, genetics, and microbiology. Notable features include rigorous peer review, rapid publication timelines for breakthrough findings, and a strong commitment to data transparency and reproducibility. While not an open access journal by default, Immunity offers open access options and facilitates broad dissemination through its high visibility and extensive indexing. Its elite standing in the field is underscored by its top-tier impact factor and its role as a leading forum for the most transformative discoveries in immunology.